An observational study in REM Sleep Behavior Disorder, sponsored by University Hospital, Clermont-Ferrand. Completed at 5 sites in France. Open to participants aged 30 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University Hospital, Clermont-Ferrand · Observational
Fantini ML, Postuma RB, Puligheddu M, Rieu I, Venel E, Figorilli M, Cochen-DeCock V, Leclair-Visonneau L, Arnaldi D, Mattioli P, Peter-Derex L, Ricordeau F, Te…PubMed 39327269 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in REM Sleep Behavior Disorder with a site in France — 6 open to participants now, 6 under way, none of them phase 3. REM Sleep Behavior Disorder · France.
Among the 15 studies in REM Sleep Behavior Disorder with a site in France, this one is the only one that started in 2019, is one of 5 observational ones, and was the 8th registered.
101 studies on the registry are indexed under REM Sleep Behavior Disorder; 45 are open to participants now.
Browse REM Sleep Behavior Disorder studies →6 of the 15 studies in REM Sleep Behavior Disorder with a site in France are open now. Recruiting first, the newest first:
University Hospital, Clermont-Ferrand · Sites in France
Ages 45–80
University Hospital, Toulouse · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+ · Healthy volunteers
Queen Mary University of London · Sites in France, Spain, United Kingdom
Ages 50+
University Hospital, Toulouse · Sites in France, Germany, Spain and 1 more country
Ages 18+ · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 32 REM Sleep Behavior Disorder studies recruiting now, 18 (56%) set no upper age limit and 4 (13%) stop at 75 or younger; 4 take children under 18; 17 take healthy volunteers.
This study: 30 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 1 started in 2019.
This study's enrollment of 188 is above the median of 138 across 48 observational studies indexed under REM Sleep Behavior Disorder.
Median enrollment 54 across the 10 interventional studies, 60 across the 5 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 9 most frequent:
University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 177 are open to participants now.
University Hospital, Clermont-Ferrand has 6 studies filed under REM Sleep Behavior Disorder — fewer than ten, so there is no comparison to draw.
1 of the studies in REM Sleep Behavior Disorder with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07706829Queen Mary University of LondonArtificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study | 2027-09-30 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in REM Sleep Behavior Disorder with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
REM (Rapid Eye Movements) Sleep Behavior Disorder (RBD) is a parasomnia characterized by episodes of elaborate or violent motor activity during dreams, which can lead to injury and sleep disruption in patient and / or his/her spouse. This is due to the loss of the normal muscle atonia during REM Sleep. RBD is often associated to neurodegenerative diseases, and may even precede them for several years as an early marker. Currently, there is no scale or tool for assessing the severity of RBD. Nevertheless, it is crucial to have a tool of severity when one wants to study the natural evolution of this disorder, as well as the possible effect of a drug in the context of a clinical trial. A Severity Scale of RBD has recently been proposed within the International RBD Study Group and an international validation study in several languages is being considered.
The main objective of this study is to validate a new scale of severity of the REM sleep behavior disorder (RBD Severity Scale or RBDSS) and to characterize its metrological properties, in particular its concurrent validity, internal consistency and reproducibility
Research involving the human person, non-interventional, category 3
80 patients with RBD of any etiology (eg Idiopathic RBD, RBD associated with Parkinson's Disease, Multiple System Atrophy, Narcolepsy etc.) and their bedpartners (if available) will be include in 5 French centers (Clermont-Ferrand, Paris, Nantes, Montpellier et Lyon) Patients, and their bedpartners (if available), will be seen 2 times at 1 week intervals.
For the patients Visit 1 (Day 0): duration : 60 minutes
Visit 2 (J7) : duration : 20 minutes
At home, patients will fill :
D8 à D36 :
D36 :
Visit 2 (D7- retest) : duration : 20 minutes
At home: bedpartners will fill:
D8 à D36 :
D36 :
Patients with RBD and their bedpartner
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
RBD patients:
Exclusion Criteria:
-- RBD patients:
patients with RBD
Other: Scale vaidation
Subjects which are the bedpartners of patients with RBD
Other: Scale vaidation
It's just filling a scale in order to validate it in French
French validation of a new scale of severity of REM Sleep behavior disorder for patient
The scale contains 8 items in the patient version. Each of them focusing on one RBD symptom, are evaluated in terms of their frequency and severity. This scale was administered at Day7 to evaluate concurrent validity, internal consistency and reproducibility
Time frame: Day 7
French validation of a new scale of severity of REM Sleep behavior disorder for patient
The scale contains 8 items in the patient version. Each of them focusing on one RBD symptom, are evaluated in terms of their frequency and severity. This scale was administered at Day 0 to evaluate concurrent validity, internal consistency and reproducibility
Time frame: Day 0
French validation of a new scale of severity of REM Sleep behavior disorder for bedpartners
The scale contains 6 items in the patient version. After two introductory questions that are not scored, the scale includes items concerning the spouse's RBD symptoms and are evaluated in terms of their frequency and severity. This scale was administered at Day 7 to to evaluate concurrent validity, internal consistency and reproducibility
Time frame: Day 7
French validation of a new scale of severity of REM Sleep behavior disorder for bedpartners
The scale contains 6 items in the patient version. After two introductory questions that are not scored, the scale includes items concerning the spouse's RBD symptoms and are evaluated in terms of their frequency and severity. This scale was administered at Day 0 to to evaluate concurrent validity, internal consistency and reproducibility
Time frame: Day 0
Evaluation of the psychometric properties of the patient scale according to the etiology of the RBD
The total pool of patients will be divided into different groups according to the etiology (RBD-Idiopathic, RBD-parkinsons disease, RBD- Multiple System Atrophy, RBD-Narcolepsy etc.) and the validity in each condition will be evaluated
Time frame: Day 7
Evaluation of the fluctuations in the frequency and severity of RBD symptoms and their "night-to-night" variability through the collection of daily data over a four-week period
In order to control variability of symptoms, patients and their bed partners will complete a Weekly Symptom Diary (weekly-RBD Questionnaire), measuring the frequency and severity of symptoms daily for 4 weeks to determine the fluctuation of symptoms over a long period
Time frame: Day 28
Evaluation of the RBD severity using Clinical Global Impression-Severity
This scale is s the only currently available measure of severity of RBD. It includes 7 categories that are from 1 to 7: Normal (no symptoms), Minimal, Light, Moderate, Marked, Severe, Very Severe
Time frame: Day 7
Ran from May 2019 to primary completion in Nov 2021, 29 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Jun 2020 → Nov 2021 and completion Sep 2020 → Nov 2021.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Fantini ML, Postuma RB, Puligheddu M, Rieu I, Venel E, Figorilli M, Cochen-DeCock V, Leclair-Visonneau L, Arnaldi D, Mattioli P, Peter-Derex L, Ricordeau F, Te…PubMed 39327269 ↗
Fantini ML, Postuma RB, Puligheddu M, Rieu I, Venel E, Figorilli M, Cochen-DeCock V, Leclair-Visonneau L, Arnaldi D, Mattioli P, Peter-Derex L, Ricordeau F, Te…PubMed 39327269 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand →